journal article·2023-10Open access

USP25 Inhibits Neuroinflammatory Responses After Cerebral Ischemic Stroke by Deubiquitinating TAB2

Zhongding Li, Baohua Liu, Kate Lykke Lambertsen, Bettina Hjelm Clausen, Zhenhu Zhu, Xue Du, Yanqi Xu, Frantz Rom Poulsen, Bo Halle, Christian Bonde, Meng Chen, Xue Wang, Dirk Schlüter, Jingyong Huang, Ari Waisman, Weihong Song, Xu Wang

Advanced Science· Volume 10· Issue 28

Abstract

Abstract Cerebral ischemic stroke is a leading cause of morbidity and mortality globally. However, the mechanisms underlying ischemic stroke injury remain poorly understood. Here, it is found that deficiency of the ubiquitin‐specific protease USP25 significantly aggravate ischemic stroke injury in mice. USP25 has no impact on neuronal death under hypoxic conditions, but reduced ischemic stroke‐induced neuronal loss and neurological deficits by inhibiting microglia‐mediated neuroinflammation. Mechanistically, USP25 restricts the activation of NF‐κB and MAPK signaling by regulating TAB2. As a deubiquitinating enzyme, USP25 removeds K63‐specific polyubiquitin chains from TAB2. AAV9‐mediated TAB2 knockdown ameliorates ischemic stroke injury and abolishes the effect of USP25 deletion. In both mouse and human brains, USP25 is markedly upregulated in microglia in the ischemic penumbra, implying a clinical relevance of USP25 in ischemic stroke. Collectively, USP25 is identified as a critical inhibitor of ischemic stroke injury and this data suggest USP25 may serve as a therapeutic target for ischemic stroke.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ubiquitin and proteasome pathways · Neuroinflammation and Neurodegeneration Mechanisms · Retinal Diseases and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health) School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou 325035 China

Department of Neurological Rehabilitation The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou 325027 China

Department of Neurobiology Research Institute of Molecular Medicine University of Southern Denmark Odense C 5000 Denmark

BRIDGE – Brain Research – Inter Disciplinary Guided Excellence Department of Clinical Research University of Southern Denmark Odense C 5000 Denmark

Department of Neurology Odense University Hospital Odense C 5000 Denmark

School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou 325035 China

Department of Neurosurgery Odense University Hospital Odense C 5000 Denmark

Institute of Medical Microbiology and Hospital Epidemiology Hannover Medical School 30625 Hannover Germany

Department of Vascular Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325015 China

Institute for Molecular Medicine Johannes Gutenberg University Mainz 55131 Mainz Germany

Key Laboratory of Alzheimer's Disease of Zhejiang Province Institute of Aging Wenzhou Medical University Wenzhou 325035 China

Funding

National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1016/S1474-4422(19)30034-110.1016/S1474-4422(19)30034-1 ↗
2. 10.1161/CIRCRESAHA.121.31994810.1161/CIRCRESAHA.121.319948 ↗
3. 10.1038/nm.250710.1038/nm.2507 ↗
4. 10.1038/s41392-022-01064-110.1038/s41392-022-01064-1 ↗
5. 10.1016/j.celrep.2018.12.05510.1016/j.celrep.2018.12.055 ↗
6. 10.1073/pnas.191642711710.1073/pnas.1916427117 ↗
7. 10.1038/s41577-019-0215-710.1038/s41577-019-0215-7 ↗
8. 10.1111/j.1749-6632.2010.05728.x10.1111/j.1749-6632.2010.05728.x ↗
9. 10.1007/s00401-018-1930-z10.1007/s00401-018-1930-z ↗
10. 10.1523/JNEUROSCI.2435-08.200810.1523/JNEUROSCI.2435-08.2008 ↗
11. 10.1016/j.it.2021.12.00510.1016/j.it.2021.12.005 ↗
12. 10.1016/j.molmed.2022.01.00610.1016/j.molmed.2022.01.006 ↗
13. 10.1038/s41380-021-01233-810.1038/s41380-021-01233-8 ↗
14. 10.1186/s12974-020-01783-810.1186/s12974-020-01783-8 ↗
15. 10.1038/ni.242710.1038/ni.2427 ↗
16. 10.1126/scisignal.200370810.1126/scisignal.2003708 ↗
17. 10.1073/pnas.150996811210.1073/pnas.1509968112 ↗
18. 10.1016/j.jcmgh.2022.07.01310.1016/j.jcmgh.2022.07.013 ↗
19. 10.1038/s43018-020-0089-410.1038/s43018-020-0089-4 ↗
20. 10.1172/JCI15217010.1172/JCI152170 ↗
21. 10.1016/j.immuni.2021.09.01410.1016/j.immuni.2021.09.014 ↗
22. 10.1007/s00401-021-02370-810.1007/s00401-021-02370-8 ↗
23. 10.1016/j.pneurobio.2016.05.00110.1016/j.pneurobio.2016.05.001 ↗
24. 10.1038/nsmb.173110.1038/nsmb.1731 ↗
25. 10.1038/emboj.2009.34510.1038/emboj.2009.345 ↗
26. 10.1016/j.molcel.2004.08.00810.1016/j.molcel.2004.08.008 ↗
27. 10.1006/geno.1999.602510.1006/geno.1999.6025 ↗
28. 10.1097/SHK.000000000000199210.1097/SHK.0000000000001992 ↗
29. 10.1038/s41467-022-29684-910.1038/s41467-022-29684-9 ↗
30. 10.1038/s41388-020-1253-010.1038/s41388-020-1253-0 ↗
31. 10.1038/nature0279410.1038/nature02794 ↗
32. 10.1016/j.immuni.2008.02.00210.1016/j.immuni.2008.02.002 ↗
33. 10.1038/ni111010.1038/ni1110 ↗
34. 10.1038/emboj.2012.24010.1038/emboj.2012.240 ↗
35. 10.1038/nature0824710.1038/nature08247 ↗
36. 10.1111/j.1600-065X.2012.01108.x10.1111/j.1600-065X.2012.01108.x ↗
37. 10.1111/febs.1520210.1111/febs.15202 ↗
38. 10.1038/s12276-022-00734-y10.1038/s12276-022-00734-y ↗
39. 10.1186/s12974-020-01921-210.1186/s12974-020-01921-2 ↗
40. 10.1038/ncomms385210.1038/ncomms3852 ↗
41. 10.15252/embj.201810094710.15252/embj.2018100947 ↗
42. 10.1007/s00401-013-1183-910.1007/s00401-013-1183-9 ↗
43. 10.1002/eji.20124267910.1002/eji.201242679 ↗
44. 10.1126/sciadv.abc570210.1126/sciadv.abc5702 ↗
45. 10.1186/s40478-020-00957-y10.1186/s40478-020-00957-y ↗
46. 10.1038/srep2929110.1038/srep29291 ↗
47. 10.1007/s00401-016-1541-510.1007/s00401-016-1541-5 ↗
48. 10.1186/1742-2094-11-12310.1186/1742-2094-11-123 ↗
49. 10.3389/fneur.2020.0044810.3389/fneur.2020.00448 ↗